Publications database

Drug profiles are scientifically sound descriptions of drugs in the form of ‘drug profiles’. Presented in a standardised way, each profile briefly gives the chemistry, pharmacology, synthesis and precursors of each substance...

Drug profiles are scientifically sound descriptions of drugs in the form of ‘drug profiles’. Presented in a standardised way, each profile briefly gives the chemistry, pharmacology, synthesis and precursors of each substance...

pThis report presents the key activities performed by the EMCDDA and Europol in 2012 and includes details of all the relevant activities in support of the implementation of Council Decision 2005/387/JHA on...

The Trends and developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy and responses. Together with...

This Thematic paper contains the results of a study that examined drug prevention interventions for minority ethnic populations in 29 European countries. A total of 33 interventions were reported to the study...

The EMCDDA treatment strategy provides a coherent strategic framework for data collection on treatment responses to drug use in Europe. Resulting from cross-unit collaboration in 2010–12, it offers a common conceptual framework...

This country overview, summarising the drug situation in Georgia, was created within the framework of the project Introducing Addictology in Educational System in Georgia and its component NDO.GE Building, financed by the...

The national drug policy of Ireland comes under the spotlight in the second volume in the EMCDDA series of Drug policy profiles. Examining the evolution of Irish drug policy through four periods...

Drugnet Europe, the EMCDDA's quarterly newsletter, provides regular information on the agency's activities to a broad readership. In this issue: EU drug markets report highlights; new EU drug strategy endorsed; upcoming risk...

At the end of September 2012, the EMCDDA and Europol examined the available information on a new psychoactive substance 5-(2-aminopropyl)indole (commonly known by the abbreviation ‘5-IT’), through a joint assessment. The two...